alovudine has been researched along with Neuroendocrine Tumors in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderoni, L; Castellucci, P; Fanti, S; Telo, S; Vichi, S; Zagni, F | 1 |
| Fisker Hag, AM; Haagen Nielsen, C; Johnbeck, CB; Kjaer, A; Knigge, U; Munk Jensen, M | 1 |
| Berthelsen, AK; Binderup, T; Federspiel, B; Johnbeck, CB; Kjaer, A; Knigge, U; Langer, SW; Loft, A | 1 |
| Billotey, C; Borson-Chazot, F; Bournaud, C; Cornu, C; Giammarile, F; Hervieu, V; Houzard, C; Janier, M; Le Bars, D; Lombard-Bohas, C; Masson, S; Scoazec, JY; Vuillez, JP; Walter, T | 1 |
1 review(s) available for alovudine and Neuroendocrine Tumors
| Article | Year |
|---|---|
Alternative and New Radiopharmaceutical Agents for Lung Cancer.
Topics: Acetates; Carbon Radioisotopes; Dideoxynucleosides; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Methionine; Misonidazole; Neoplasm Staging; Neuroendocrine Tumors; Peptides; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
2 trial(s) available for alovudine and Neuroendocrine Tumors
| Article | Year |
|---|---|
Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 Patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Dideoxynucleosides; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography | 2016 |
18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours.
Topics: Adult; Aged; Cell Differentiation; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms | 2011 |
1 other study(ies) available for alovudine and Neuroendocrine Tumors
| Article | Year |
|---|---|
18F-FDG and 18F-FLT-PET imaging for monitoring everolimus effect on tumor-growth in neuroendocrine tumors: studies in human tumor xenografts in mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Drug Monitoring; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Mice; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Tomography, X-Ray Computed; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2014 |